Tag Archives: from

AstraZeneca’s $39B Alexion buyout scores EU blessing but still awaits key nod from the UK

AstraZeneca’s $ 39 billion takeover of rare disease specialist Alexion has another regulatory blessing in the bag, but the pair are still holding out for a key nod from the U.K. to settle the deal.  AstraZeneca on Tuesday said that the European Union has approved its acquisition of Boston-based Alexion, inching closer toward its goal… Read More »

‘An Arm and a Leg’: Tips for Fighting Medical Bills from ProPublica’s Marshall Allen

Can’t see the audio player? Click here to listen. Veteran health journalist Marshall Allen has been exposing health care grifters for years. Now, he’s written a book about how to fight them. Host Dan Weissmann spoke with Allen about some of the best tips from “Never Pay the First Bill: And Other Ways to Fight the… Read More »